What the page should put in plain writing
Copy the offer into a document you can keep. Ask for the legal name of the organization delivering the service, not only the brand name. Ask which licensed professionals are involved, what each role does, and whether one clinician is accountable for the care described. Confirm what the reader actually receives each week or month: calls, messages, classes, devices, supplies, reports, or referrals. Confirm the total cost, including enrollment fees, recurring charges, supplies, shipping, taxes, and any item the program says is not covered. Ask how renewal, cancellation, and refunds work. Ask what health data is collected, who can see it, whether it is shared or sold, and which privacy rules the program says apply. Get these answers by email or a document, not spoken assurances. If the page hides the total behind “as low as” language, request a written all-in figure. A marketing claim describes what the seller wants the reader to believe; a clinical claim points to research or professional judgment; a payer or regulator recognition points to an external body’s decision. Those kinds of support differ; one does not substitute for another.
Claim patterns that should slow you down
Google publisher policy governs where ads may appear; it is evidence about advertising integrity, not proof that a health claim works. The retrieved policy text still helps because it names promise shapes that the company’s ad rules treat as deceptive or restricted. Those categories can tell a reader when to stop and ask for documentation.
| Policy category | What the retrieved policy says | Example cited | Source URL |
|---|
| Unreliable and harmful claims | Ads are not allowed on harmful health claims or content contradicting authoritative scientific consensus | Anti-vaccine advocacy; AIDS or COVID-19 denial; conversion therapy | https://support.google.com/adsense/answer/9335564 |
| Unapproved drugs and supplements | Restricted: promotion of unapproved drugs and supplements, including listed products and those with active pharmaceutical or dangerous ingredients | Listed products; ephedra; herbal or dietary supplements with drug ingredients; confusingly similar names | https://support.google.com/publisherpolicies/answer/10437888 |
| Prescription drugs | Restricted: facilitating online sale of prescription drugs | Selling prescription drugs; online pharmacies | https://support.google.com/publisherpolicies/answer/10437489 |
| Impossible promises (AFS search-ads rule) | Egregious violation: concrete, explicitly stated promises that cannot be fulfilled | Free or cash offers; promises to hire; unreasonably cheap offers such as a $1000 vehicle; loans; admission | https://support.google.com/adsense/answer/14638581 |
A “free” or cash inducement is not proof of fraud, but concrete, explicit promises that cannot be fulfilled are classified as egregious, with free or cash offers and unreasonably cheap offers as examples. A guarantee of a specific diabetes outcome belongs in the same pause-and-verify zone: ask for published research, not only testimonials. Supplement pitches, and products named to resemble drugs, fall under a restricted category tied to a non-exhaustive list. Offers that funnel readers into buying prescription medication online sit under a separate prescription restriction. Content that contradicts authoritative scientific consensus raises another concern. Google’s traffic-acquisition policy also requires a source to describe the landing page accurately and bars promises of offers absent there. These are advertising-integrity signals, not clinical judgments about any program.
Questions to settle before enrollment
Use one email thread and ask for written answers.
- Who is clinically accountable? Obtain names, roles, and how concerns are routed.
- How does the program coordinate with the reader’s own clinician? Ask what is shared, by whom, and when.
- What is every fee, including later charges and uncovered items? Request an all-in total.
- What are the cancellation, refund, and renewal mechanics? Confirm before entering card details.
- What data is collected, shared, or sold, and can consent be separated from enrollment?
- What evidence will the program send? Published research differs from testimonials.
If a representative cannot answer, ask for escalation and wait. A sales script is not written terms.
Questions for your own clinician
This article cannot judge whether a program fits a reader’s condition, medications, or glucose targets. Prepare a short list for the clinician who knows that care: What would this program duplicate, replace, or conflict with in my current plan? Which records should be shared, and which readings or symptoms should prompt a call? Who at the program will communicate with you, and how? Ask the program to answer in writing so the clinician can review it. A clinician’s review of the program’s role differs from a sales page.
Red flags and safer next steps
Treat urgency, countdowns, “last chance” pricing, a card request before terms, bundled data consent, and failure to identify the legal operator as reasons to pause. So are guaranteed outcomes, a supplement presented as a cure, and a path ending in an online prescription purchase. Instead, request the written terms, compare two offers using the same questions, and verify the delivering organization’s identity. If answers stay vague, do not enroll. Slower verification is the safer default.
Limits of this evidence
No clinical, pricing, coverage, or program-specific evidence was retrieved for this article. It contains no program prices, outcome figures, coverage promises, or named-program verdicts. Google’s policy documents describe advertising-monetization rules, can change, and are not medical review. Program availability, eligibility, cost, and cancellation terms vary by state, payer, and provider, so confirm them with the program and the reader’s plan. Check the policy references against live pages. Nothing here is medical advice.
研究の知恵